华绿生物
(300970)
| 流通市值：30.62亿 | | | 总市值：39.62亿 |
| 流通股本：9475.74万 | | | 总股本：1.23亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 414,243,699.16 | 1,291,890,340.95 | 867,669,135 | 498,535,994.34 |
| 营业收入 | 414,243,699.16 | 1,291,890,340.95 | 867,669,135 | 498,535,994.34 |
| 二、营业总成本 | 297,997,767.92 | 1,179,931,454.88 | 858,235,706.04 | 560,076,558.51 |
| 营业成本 | 281,135,029.26 | 1,083,907,393.68 | 790,102,924.63 | 515,402,873.64 |
| 税金及附加 | 227,482.41 | 791,377.64 | 522,799.82 | 329,368.39 |
| 销售费用 | 2,887,448.59 | 10,473,593.71 | 6,634,235.19 | 4,497,720.29 |
| 管理费用 | 14,041,849.88 | 58,830,903.55 | 44,033,748.63 | 30,381,317.32 |
| 研发费用 | 3,646,290.12 | 17,368,705.95 | 11,369,406.35 | 5,970,951.72 |
| 财务费用 | -3,940,332.34 | 8,559,480.35 | 5,572,591.42 | 3,494,327.15 |
| 其中:利息费用 | - | 15,970,456.41 | 11,302,821.01 | 7,400,329.49 |
| 其中:利息收入 | - | 7,442,420.28 | 5,753,565.86 | 3,924,982.95 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | - | 0 | - |
| 资产处置收益 | 101,081.15 | -2,147,494.3 | -438,905.09 | -269,291.73 |
| 资产减值损失(新) | 107,757.18 | 151,765.13 | -699,213.55 | -670,756.49 |
| 信用减值损失(新) | - | -80,456.62 | 143,613.37 | 143,613.37 |
| 其他收益 | 2,788,328.11 | 13,977,493.26 | 8,504,609.2 | 5,359,937.43 |
| 四、营业利润 | 119,243,097.68 | 123,860,193.54 | 16,943,532.89 | -56,977,061.59 |
| 加:营业外收入 | 153,767.54 | 577,208.43 | 373,579.1 | 202,119.63 |
| 减:营业外支出 | 125,150.13 | 5,132,322.96 | 464,686.3 | 198,188.42 |
| 五、利润总额 | 119,271,715.09 | 119,305,079.01 | 16,852,425.69 | -56,973,130.38 |
| 减:所得税费用 | - | 49,311.04 | 8,555.2 | -44.8 |
| 六、净利润 | 119,271,715.09 | 119,255,767.97 | 16,843,870.49 | -56,973,085.58 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | - | 119,255,767.97 | - | -56,973,085.58 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 109,891,608.16 | 110,268,302.23 | 16,333,517.64 | -53,694,652.84 |
| 少数股东损益 | 9,380,106.93 | 8,987,465.74 | 510,352.85 | -3,278,432.74 |
| 扣除非经常损益后的净利润 | 109,567,475.54 | 112,747,362.5 | 15,529,540.25 | -54,208,168.34 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.91 | 0.93 | 0.14 | -0.45 |
| (二)稀释每股收益 | 0.91 | 0.93 | 0.14 | -0.45 |
| 九、综合收益总额 | 119,271,715.09 | 119,255,767.97 | 16,843,870.49 | -56,973,085.58 |
| 归属于母公司股东的综合收益总额 | 109,891,608.16 | 110,268,302.23 | 16,333,517.64 | -53,694,652.84 |
| 归属于少数股东的综合收益总额 | 9,380,106.93 | 8,987,465.74 | 510,352.85 | -3,278,432.74 |
| 公告日期 | 2026-04-22 | 2026-04-22 | 2025-10-24 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |